Specific gene suppression using antisense strategy for growth suppression of glioma

Medical Electron Microscopy

Volumn 37, Issue 3, 2004, Pages 158-161

  Matsuno, Akira ^a   Nagashima, Tadashi ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Antisense oligonucleotide; Gene suppression; Glioma; Growth suppression; Microtubule

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DNA TOPOISOMERASE (ATP HYDROLYSING); FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MICROTUBULE ASSOCIATED PROTEIN 1; PROTEIN KINASE C ALPHA; TELOMERASE; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN; FGFR1 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN A;

ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; GLIOMA; GLIOMA CELL; GROWTH INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; BRAIN TUMOR; CELL CULTURE; CELL DIVISION; DRUG EFFECT; GENETICS; HUMAN; METABOLISM;

BRAIN NEOPLASMS; CELL DIVISION; GLIOMA; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; TELOMERASE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 16644362919     PISSN: 09184287     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00795-004-0251-6     Document Type: Review

References (13)

1. Belikova AM, Zarytova VF, Grineva NI (1967) Synthesis of ribonucleosides and diribonucleoside phosphates containing 2-chloroethylamine and nitrogen mustard residues. Tetrahedron Lett 37:3557-3562
2. Zamecnik PC, Stephenson ML (1978) Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci USA 75:280-284
3. Rothenberg M, Johnson G, Laughlin C, Green I, Cradock J, Sarver N, Cohen JS (1989) Oligodeoxynucleotides as anti-sense inhibitors of gene expression: therapeutic implications. J Natl Cancer Inst 81:1539-1544
4. Stein CA, Cheng YC (1993) Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261:1004-1012
5. Matsuno A, Katayama H, Murakami M, Nagashima T (2004) In vivo growth suppression of rat C6 glioma transplanted in rat brain using antisense oligonucleotide for microtubule-associated protein-1A messenger ribonucleic acid. Br J Neurosurg (in press)
6. Matsuno A, Nagashima T, Katayama H, Tamura A (2000) In vitro and in vivo delivery of antisense oligodeoxynucleotides using lipofection: application of antisense technique to growth suppression of experimental glioma. In: Phillips MI (ed) Antisense techniques: methods in enzymology, vol 313. Academic Press, Orlando, pp 359-372
7. Tang P, Jasser SA, Sung JC, Shi Y, Steck PA, Yung WK (1999) Transforming growth factor-alpha antisense vectors can inhibit glioma cell growth. J Neuro-oncol 43:127-135
8. Morrison RS (1991) Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J Biol Chem 266:728-734
9. Yamada SM, Yamaguchi F, Brown R, Berger MS, Morrison RS (1999) Suppression of glioblastoma cell growth following antisense oligonucleotide- mediated inhibition of fibroblast growth factor receptor expression. Glia 28:66-76
10. Cheng SY, Huang HJ, Nagane M, Ji XD, Wang D, Shih CC, Arap W, Huang CM, Cavenee WK (1996) Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci USA 93:8502-8507
11. Yamaguchi F, Morrison RS, Takahashi H, Teramoto A (1999) Anti-telomerase therapy suppressed glioma proliferation. Oncol Rep 6:773-776
12. Shin M, Kimura S, Nagao S (1999) Inhibition of topoisomerase II alpha subunit de novo synthesis by specific antisense oligonucleotides suppresses human glioma T98G cell growth. Neurol Med Chir (Tokyo) 39:199-205
13. Yazaki T, Ahmad S, Chahlavi A, Zylber-Katz E, Dean NM, Rabkin SD, Martuza RL, Glazer RI (1996) Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide. Mol Pharmacol 50:236-242